华邦健康：产品“糠酸莫米松乳膏”取得注册证

Core Viewpoint - Huabang Health has received approval for the registration of Mometasone Furoate Cream from the National Medical Products Administration, which may enhance its product portfolio and revenue potential [1] Company Summary - Huabang Health's subsidiary, Chongqing Huabang Pharmaceutical Co., Ltd., has obtained two specifications of the drug registration certificate for Mometasone Furoate Cream [1] - As of the latest report, Huabang Health has a market capitalization of 9.3 billion yuan [1] Industry Summary - For the first half of 2025, Huabang Health's revenue composition is as follows: pesticides account for 56.82%, pharmaceuticals for 27.33%, tourism for 8.29%, others for 4.34%, and medical services for 3.21% [1]